Testing effectiveness (Phase 2)UnknownNCT05472610What this trial is testingStudy of Efficacy of BZ019 in Large B-cell LymphomaWho this might be right forLarge B-cell Lymphoma Shanghai Mengchao Cancer Hospital 36
Early research (Phase 1)Active Not RecruitingNCT03684889What this trial is testingCD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or LymphomaWho this might be right forLeukemiaLymphoma Seattle Children's Hospital 16
Early research (Phase 1)Looking for participantsNCT07239323What this trial is testingIn VIVO CAR-T Therapy for Relapsed/Refractory Hematological MalignanciesWho this might be right forB-Acute Lymphoblastic LeukemiaB Cell Non-Hodgkin's LymphomaMultiple Myeloma Chongqing Precision Biotech Co., Ltd 24
Early research (Phase 1)UnknownNCT03030976What this trial is testingCD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus Erythematosus (SLE) Shanghai GeneChem Co., Ltd. 5
Very early researchNot Yet RecruitingNCT06933563What this trial is testingUCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia GravisWho this might be right forMyasthenia Gravis Zhejiang University 18
Early research (Phase 1)WithdrawnNCT05513612What this trial is testingNovel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid MalignanciesWho this might be right forAcute Myeloid Leukemia (AML)B-cell Non-Hodgkin's Lymphoma (B-NHL)Multiple Myeloma (MM)+2 more Shanghai Pudong Hospital
Testing effectiveness (Phase 2)Active Not RecruitingNCT04787263What this trial is testingCD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PMLWho this might be right forAcute Lymphoblastic LeukemiaDiffuse Large B Cell LymphomaPrimary Mediastinal Lymphoma Bambino Gesù Hospital and Research Institute 32
Early research (Phase 1)Study completedNCT04696432What this trial is testingC-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's B-cell Lymphoma Tianjin Medical University Cancer Institute and Hospital 7
Early research (Phase 1)Temporarily pausedNCT06792344What this trial is testingClinical Study of CD19 CAR-T in the Treatment of Refractory Systemic SclerosisWho this might be right forSystemic Sclerosis (SSc) The Children's Hospital of Zhejiang University School of Medicine 12
Large-scale testing (Phase 3)Looking for participantsNCT07188558What this trial is testingInvestigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell TherapyWho this might be right forLarge B-cell LymphomaLymphoma, B-CellRelapsed Non-Hodgkin Lymphoma+6 more Lyell Immunopharma, Inc. 400
Early research (Phase 1)Study completedNCT02659943What this trial is testingT Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell MalignanciesWho this might be right forLymphoma, B-CellLymphoma, Non-hodgkins National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Looking for participantsNCT06762431What this trial is testingPhase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients.Who this might be right forChronic Lymphocytic Leukaemia (CLL)Small Lymphocytic Lymphoma (SLL) Vitebsk Regional Clinical Cancer Centre 24
Very early researchUnknownNCT05105867What this trial is testingCD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell MalignanciesWho this might be right forRelapsed or Refractory B-cell Acute Lymphoblastic LeukemiaRelapsed or Refractory B-cell Non-hodgkin Lymphoma 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 15
Early research (Phase 1)UnknownNCT05210907What this trial is testingClinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic LeukemiaWho this might be right forB-cell Acute Lymphoblastic Leukemia Seoul National University Hospital 5
Early research (Phase 1)Looking for participantsNCT01853631What this trial is testingActivated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)Who this might be right forNon-Hodgkin LymphomaChronic Lymphocytic LeukemiaAcute Lymphocytic Leukemia Baylor College of Medicine 64
Testing effectiveness (Phase 2)Looking for participantsNCT05442515What this trial is testingCD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell MalignanciesWho this might be right forB-NHLB-Non Hodgkin LymphomaAcute Lymphocytic Leukemia+8 more National Cancer Institute (NCI) 130
Very early researchUnknownNCT04156243What this trial is testingCD19 CARvac T Cells for Patients With Relapsed / Refractory B Cell MalignanciesWho this might be right forB Cell LymphomaB Cell Leukemia iCell Gene Therapeutics 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT07461831What this trial is testingCD19/ CD22 Bispecific CAR-T Cell Therapy for Relapsed/ Refractory Large B-cell LymphomaWho this might be right forLarge B-Cell Lymphoma (LBCL) Beijing Tongren Hospital 100
Very early researchUnknownNCT05085431What this trial is testingCD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's SyndromeWho this might be right forSjogren's SyndromeAutoimmune Diseases Zhejiang University 9
Not applicableLooking for participantsNCT07681388What this trial is testingCD19 CAR-T Therapy for Refractory Pemphigus VulgarisWho this might be right forPemphigus Vulgaris Jinbo Chen 3